Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Integrin αvβ6-targeted PET in Malignant Tumors
Where
Wuhan
Age
18 years to 85 years
People
200
Run by
Zhongnan Hospital
See details and how to joinNCT05835570
Phase 4Not yet taking people in China
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
Where
Shenyang
Age
18 years and over
People
31
Run by
China Medical University, China
See details and how to joinNCT06951841
Phase 1Not yet taking people in China
To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors
Where
Guanzhou
Age
18 years and over
People
66
Run by
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT06948539
No phaseTaking people
A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
Where
Guangzhou
People
1,000
Run by
Guangzhou Medical University
See details and how to joinNCT06718972
No phaseTaking people
Sleep Disorders and Tumor Immune Microenvironment
Where
Shanghai
Age
18 years to 70 years
People
400
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT06941948
Phase 4Not yet taking people in China
Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
Where
Beijing
Age
18 years to 75 years
People
50
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06931145
No phaseTaking people
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Where
Nanjing
Age
18 years to 75 years
People
20
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT06937112
Phase 2Taking people
Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC
Where
Tianjin
Age
18 years to 75 years
People
38
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06939127
Phase 1/2Taking people
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
Where
Shanghai
Age
18 years to 75 years
People
400
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06754930
No phaseTaking people
Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer
Where
Beijing, Hohhot, Kunming
Age
18 years and over
People
500
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06926179
No phaseTaking people
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
Where
Beijing
Age
18 years and over
People
1,000
Run by
Peking University People's Hospital
See details and how to joinNCT06930807
Phase 1Taking people
A Study Evaluating the Effect of Aumolertinib on the Pharmacokinetics of Midazolam in Patients With NSCLC
Where
Hangzhou
Age
18 years and over
People
20
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT06926413
Phase 1Taking people
Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors
Where
Tianjin
Age
18 years to 75 years
People
780
Run by
Hansoh BioMedical R&D Company
See details and how to joinNCT06621563
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs
Where
Beijing
Age
18 years and over
People
350
Run by
Shanghai JMT-Bio Inc.
See details and how to joinNCT06829459
Phase 2Taking people
Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)
Where
Guangzhou
Age
18 years to 75 years
People
45
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06911606
Phase 1Taking people
Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma
Where
Shanghai
Age
18 years and over
People
60
Run by
Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06903117
No phaseNot yet taking people in China
SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis
Where
Fuzhou
Age
18 years and over
People
200
Run by
Fuzhou General Hospital
See details and how to joinNCT06772363
No phaseNot yet taking people in China
SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer
Where
Fuzhou
Age
18 years and over
People
200
Run by
Fuzhou General Hospital
See details and how to joinNCT06775015
No phaseNot yet taking people in China
SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules
Where
Fuzhou
Age
18 years and over
People
200
Run by
Fuzhou General Hospital
See details and how to joinNCT06775587
Phase 1/2Enrolling by invitation
Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
Where
Jinan
Age
18 years and over
People
100
Run by
Man Hu
See details and how to joinNCT06690216
Phase 2Taking people
A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases
Where
Shanghai
Age
18 years and over
People
97
Run by
Shanghai Cancer Hospital, China
See details and how to joinNCT06901817
No phaseTaking people
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Where
Guangzhou
Age
18 years to 100 years
People
10,000
Run by
ChromX Health
See details and how to joinNCT06528418
Phase 2Not yet taking people in China
Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.
Where
Baoding, Beijing, Changchun, Changsha, Dongguan, Foshan, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Lanzhou, Nantong, Shenyang, Tianjin, Wuhan, Xi’an, Zhengzhou
Age
18 years and over
People
100
Run by
Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT06885840
No phaseEnrolling by invitation
Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients
Where
Jinan
Age
60 years to 80 years
People
43
Run by
Qianfoshan Hospital
See details and how to joinNCT06883136
No phaseEnrolling by invitation
LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer
Where
Beijing
Age
18 years to 80 years
People
167
Run by
Peking University Third Hospital
See details and how to joinNCT06876675